Radiopharm Theranostics Limited (ASX:RAD)

Radiopharm Theranostics Revenue

In the fiscal year ending June 30, 2026, Radiopharm Theranostics had annual revenue of 13.50M AUD with 3.85% growth. Radiopharm Theranostics had revenue of 7.30M in the half year ending June 30, 2026.

• Revenue: 13.50M
• Revenue Growth: +3.85%
• P/S Ratio: 1.93
• Revenue / Employee: 964.45K
• Employees: 14
• Market Cap: 26.03M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	13.50M	500.30K	3.85%
Jun 30, 2025	13.00M	11.41M	716.81%
Jun 30, 2024	1.59M	-4.62M	-74.37%
Jun 30, 2023	6.21M	-	-
Jun 30, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 1, 2026

Data Sources Report a data error